Beta Bionics, Inc. Common Stock (BBNX)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Beta Bionics, Inc. Common Stock (BBNX) is listed on Nasdaq, where it has traded since January 30, 2025.
- Listed On
- Nasdaq
- Listed Since
- January 30, 2025
- Employees
- 423
- Market Cap
- $821M
About Beta Bionics, Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 130 institutions reported holding BBNX, with 48.0 million shares worth $752.4 million in aggregate. The largest reported holder was Eventide Asset Management, with 6.3 million shares worth $98.1 million. Of the 5 largest holders listed below, 4 added shares and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Eventide Asset Management | 6,253,673 | $98M | Added 5.18% |
| Soleus Capital Management | 4,393,714 | $69M | Added 0.9% |
| Morgan Stanley | 4,266,822 | $67M | Added 0.93% |
| Sands Capital Ventures | 3,708,043 | $58M | Unchanged |
| BlackRock | 3,340,171 | $52M | Added 9.92% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BBNX?
Beta Bionics, Inc. Common Stock (BBNX) is listed on Nasdaq, where it has traded since January 30, 2025.
Who are the largest institutional holders of BBNX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BBNX were Eventide Asset Management, Soleus Capital Management and Morgan Stanley.
How many institutions own BBNX?
130 institutions reported a position in BBNX for the quarter ended June 30, 2026, worth $752.4 million in total.
Did institutions buy or sell BBNX last quarter?
Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for BBNX.
Every reported institutional holder, plus insider and congressional trades in BBNX, on SentiSense.